My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 385

    1.

    Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

    Harnaha J, Machen J, Wright M, Lakomy R, Styche A, Trucco M, Makaroun S, Giannoukakis N.

    Diabetes. 2006 Jan;55(1):158-70.PMID: 16380489 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells.

    Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

    J Immunol. 2004 Oct 1;173(7):4331-41.PMID: 15383562 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.

    Gaudreau S, Guindi C, Ménard M, Besin G, Dupuis G, Amrani A.

    J Immunol. 2007 Sep 15;179(6):3638-47.PMID: 17785799 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.

    Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST.

    Diabetes. 2009 Jul;58(7):1568-77. Epub 2009 Mar 31.PMID: 19336675 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.

    Ly D, Mi QS, Hussain S, Delovitch TL.

    J Immunol. 2006 Sep 15;177(6):3695-704.PMID: 16951329 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro]

    Wang ZH, Zhu JY, Li T, Leng XS.

    Zhonghua Yi Xue Za Zhi. 2008 Mar 25;88(12):844-7. Chinese. PMID: 18756991 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

    Yates J, Rovis F, Mitchell P, Afzali B, Tsang JY, Garin M, Lechler RI, Lombardi G, Garden OA.

    Int Immunol. 2007 Jun;19(6):785-99. Epub 2007 Jun 1.PMID: 17545278 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

    Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F.

    Diabetes. 2005 Jan;54(1):78-84.PMID: 15616013 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?

    Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B.

    Gene Ther. 2004 Oct;11(20):1487-96.PMID: 15343360 [PubMed - indexed for MEDLINE]Related articles

    11.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes.

    Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R.

    J Exp Med. 2005 Apr 18;201(8):1333-46.PMID: 15837817 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.

    Ahn JS, Krishnadas DK, Agrawal B.

    Int Immunol. 2007 Mar;19(3):227-37. Epub 2007 Feb 7.PMID: 17289657 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.

    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.

    Clin Immunol. 2006 Apr;119(1):21-31. Epub 2006 Jan 9.PMID: 16406844 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cutting edge: IL-4-induced protection of CD4+CD25- Th cells from CD4+CD25+ regulatory T cell-mediated suppression.

    Pace L, Rizzo S, Palombi C, Brombacher F, Doria G.

    J Immunol. 2006 Apr 1;176(7):3900-4.PMID: 16547222 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.

    Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H.

    J Immunol. 2005 Nov 1;175(9):6107-16.PMID: 16237107 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

    Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, Verdaguer J, Santamaria P.

    Immunity. 2003 Dec;19(6):877-89.PMID: 14670304 [PubMed - indexed for MEDLINE]Related articles

    18.

    CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

    Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM.

    J Exp Med. 2004 Jun 7;199(11):1467-77.PMID: 15184500 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.

    Diabetes. 2009 Jan;58(1):146-55. Epub 2008 Nov 4.PMID: 18984738 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity